CME
Which Resected Stage II Melanoma Patients Benefit from Adjuvant ICI Therapy?
July 17, 2023
Host: Nikhil I. Khushalani, MD
This program is designed to improve clinicians’ knowledge of the latest clinical trial data surrounding the use of immunotherapy for the adjuvant treatment of patients with melanoma. The program addresses clinical
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!